Katharine Peterson

Chief Accounting Officer, Acrivon Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 18, 2026Sold 101 shares at $2.01 of Acrivon Therapeutics, Inc.²
May 18, 2026Granted 14,227 shares of Acrivon Therapeutics, Inc.³
May 14, 2026Shares withheld for tax 99 shares at $1.92 of Acrivon Therapeutics, Inc.⁴
Feb 14, 2026Shares withheld for tax 116 shares at $1.63 of Acrivon Therapeutics, Inc.⁵
Nov 14, 2025Shares withheld for tax 99 shares at $2.24 of Acrivon Therapeutics, Inc.⁶
Aug 14, 2025Shares withheld for tax 99 shares at $1.39 of Acrivon Therapeutics, Inc.⁷
May 14, 2025Shares withheld for tax 99 shares at $1.14 of Acrivon Therapeutics, Inc.⁸
Feb 14, 2025Shares withheld for tax 116 shares at $5.42 of Acrivon Therapeutics, Inc.⁹
Nov 14, 2024Shares withheld for tax 99 shares at $7.92 of Acrivon Therapeutics, Inc.¹⁰
Aug 14, 2024Shares withheld for tax 99 shares at $7.02 of Acrivon Therapeutics, Inc.¹¹
May 14, 2024Shares withheld for tax 99 shares at $8.36 of Acrivon Therapeutics, Inc.¹²

The numbers on this page point here. Each one links to the record it came from.